What Researchers Did
Researchers randomized 70 patients with depression into two groups, with one receiving escitalopram alone and the other receiving escitalopram combined with hyperbaric oxygen, to assess treatment efficacy and cognitive function over six weeks.
What They Found
After two weeks, the Hamilton Depression Scale (HAMD) scores showed a statistically significant difference between the two groups (P<0.05), with the combined therapy group showing greater improvement. This significant difference in HAMD scores persisted at four and six weeks (P<0.05), and Montreal Cognitive Assessment (MoCA) scores also significantly improved in the combined group at four and six weeks (P<0.05).
What This Means for Canadian Patients
This study suggests that adding hyperbaric oxygen therapy to escitalopram might offer a faster and more effective treatment for depression and could also help improve cognitive function. This could potentially provide an additional therapeutic option for Canadian patients struggling with depression, especially those experiencing cognitive difficulties.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in China.
Study Limitations
A limitation of this study is its relatively small sample size of 70 patients and its single-center design, which may limit the generalizability of the findings.